Literature DB >> 6029949

Thirty years of haemophilia treatment in Oxford.

R Biggs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6029949     DOI： 10.1111/j.1365-2141.1967.tb00755.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  5 in total

1.  The history of haemophilia.

Authors:  G I Ingram
Journal:  J Clin Pathol       Date:  1976-06       Impact factor: 3.411

2.  Aggregation of human platelets by commercial preparations of bovine and porcine antihaemophilic globulin.

Authors:  C D Forbes; R D Barr; G P McNicol; A S Douglas
Journal:  J Clin Pathol       Date:  1972-03       Impact factor: 3.411

Review 3.  The role of emicizumab, a bispecific factor IXa- and factor X-directed antibody, for the prevention of bleeding episodes in patients with hemophilia A.

Authors:  Tristan Knight; Michael U Callaghan
Journal:  Ther Adv Hematol       Date:  2018-10-10

Review 4.  The legacy of haemophilia: Memories and reflections from three survivors.

Authors:  Albert Farrugia; Cees Smit; Andrea Buzzi
Journal:  Haemophilia       Date:  2022-05-19       Impact factor: 4.263

Review 5.  Protein-Engineered Coagulation Factors for Hemophilia Gene Therapy.

Authors:  Benjamin J Samelson-Jones; Valder R Arruda
Journal:  Mol Ther Methods Clin Dev       Date:  2018-12-31       Impact factor: 6.698
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.